James Ranger‐Moore

PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project

Fred R. Hirsch, Abigail McElhinny, Dave Stanforth et al. · Journal of Thoracic Oncology · 2016 · 1.2K citations · Full text

Cancer Immunosurveillance, Advanced Lung Disease, Medicine +8

Effects of Dosing Condition on the Oral Bioavailability of Green Tea Catechins after Single-Dose Administration of Polyphenon E in Healthy Individuals

H.‐H. Sherry Chow, Iman A. Hakim, Donna R. Vining et al. · Clinical Cancer Research · 2005 · 396 citations

Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease

Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine et al. · Drug Metabolism and Disposition · 2009 · 342 citations · Full text

Changes in Water Mobility Measured by Diffusion MRI Predict Response of Metastatic Breast Cancer to Chemotherapy

Rebecca J. Theilmann, Rebecca Borders, Theodore P. Trouard et al. · Neoplasia · 2004 · 253 citations · Full text

Engineering, Oncologic Imaging, Pathology +16

Bigger May be Better, But is Older Wiser? Organizational Age and Size in the New York Life Insurance Industry

James Ranger‐Moore · American Sociological Review · 1997 · 230 citations